Explore

Trendline Trendline
Aptar Pharma Advances FDA-Funded Research on Next-Generation Inhaler Propellants

Aptar Pharma Advances FDA-Funded Research on Next-Generation Inhaler Propellants

Aptar Pharma Advances FDA-Funded Research on Next-Generation Inhaler Propellants
Trendline Trendline
Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment

Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment

Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment
Trendline Trendline
Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment

Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment

Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment
Trendline Trendline
Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors
Trendline Trendline
Stoke Therapeutics Reports Positive Data on Zorevunersen for Dravet Syndrome

Stoke Therapeutics Reports Positive Data on Zorevunersen for Dravet Syndrome

Stoke Therapeutics Reports Positive Data on Zorevunersen for Dravet Syndrome
Trendline Trendline
DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke

DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke

DiaMedica Therapeutics Reports Financial Results and Advances Clinical Trials for Preeclampsia and Stroke
Trendline Trendline
Harbour BioMed Receives FDA Clearance for New Cancer Treatment Trial

Harbour BioMed Receives FDA Clearance for New Cancer Treatment Trial

Harbour BioMed Receives FDA Clearance for New Cancer Treatment Trial
Trendline Trendline
Diakonos Oncology Receives FDA Fast Track Designation for Melanoma Treatment

Diakonos Oncology Receives FDA Fast Track Designation for Melanoma Treatment

Diakonos Oncology Receives FDA Fast Track Designation for Melanoma Treatment
Trendline Trendline
Diakonos Oncology's DOC1021 Receives FDA Fast Track for Melanoma Treatment

Diakonos Oncology's DOC1021 Receives FDA Fast Track for Melanoma Treatment

Diakonos Oncology's DOC1021 Receives FDA Fast Track for Melanoma Treatment
Trendline Trendline
Vistagen Completes Phase 3 Study for Fasedienol in Social Anxiety Disorder

Vistagen Completes Phase 3 Study for Fasedienol in Social Anxiety Disorder

Vistagen Completes Phase 3 Study for Fasedienol in Social Anxiety Disorder
Trendline Trendline
Altasciences and Certara Partner to Enhance Early Drug Development with Model-Informed Approaches

Altasciences and Certara Partner to Enhance Early Drug Development with Model-Informed Approaches

Altasciences and Certara Partner to Enhance Early Drug Development with Model-Informed Approaches
Trendline Trendline
Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD

Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD

Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD